China's healthcare reforms generate uncertainty for its domestic pharmaceutical market.
Jon Zifferblatt
Advertisement
Articles by Jon Zifferblatt
Advertisement
Latest Updated Articles
Preparing For the New ChinaPublished: February 1st 2012 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
